Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07135596) titled 'A Prospective, Multi-center Study of the Effectiveness and Safety of OviTex(R) PRS in Breast Reconstruction' on Aug. 14.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Tela Bio Inc
Condition:
Breast Reconstruction
Intervention:
Device: OviTex PRS
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: December 2025
Target Sample Size: 235
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07135596
Published by HT Digital Content Services with permissi...